|
RQCD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.876470E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.03170000000674E-05 |
| Normal-vs-Stage2 |
7.859400E-01 |
| Normal-vs-Stage3 |
6.470000E-01 |
| Normal-vs-Stage4 |
8.020800E-01 |
| Stage1-vs-Stage2 |
8.893800E-02 |
| Stage1-vs-Stage3 |
6.037600E-02 |
| Stage1-vs-Stage4 |
2.253800E-01 |
| Stage2-vs-Stage3 |
9.452400E-01 |
| Stage2-vs-Stage4 |
9.590800E-01 |
| Stage3-vs-Stage4 |
9.974400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.552200E-04 |
| Normal-vs-AfricanAmerican |
3.709600E-02 |
| Normal-vs-Asian |
7.782000E-01 |
| Caucasian-vs-AfricanAmerican |
7.577400E-01 |
| Caucasian-vs-Asian |
6.014800E-01 |
| AfricanAmerican-vs-Asian |
6.711800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.85199999997088E-06 |
| Normal-vs-Female |
3.816200E-01 |
| Male-vs-Female |
1.214900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.344700E-03 |
| Normal-vs-Extreme_Weight |
1.22200000007844E-07 |
| Normal-vs-Obese |
3.729400E-01 |
| Normal-vs-Extreme_Obese |
1.520420E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.988420E-01 |
| Normal_Weight-vs-Obese |
1.989620E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.957200E-01 |
| Extreme_Weight-vs-Obese |
6.644800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.445400E-01 |
| Obese-vs-Extreme_Obese |
4.095000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.623200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.600200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.628760E-04 |
| Normal-vs-Age(81-100Yrs) |
2.296900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.404400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.883000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.716500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.118200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.961900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.366000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.65270000041762E-07 |
| Normal-VS-Type2 PRCC |
3.255700E-02 |
| Normal-VS-KIRP CIMP |
4.520400E-02 |
| Normal-VS-Unclassified PRCC |
8.174400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.291030E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.99899999962095E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.435720E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.981400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.036610E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.876500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.259600E-03 |
| Normal-vs-N1 |
2.718600E-01 |
| Normal-vs-N2 |
4.369600E-01 |
| N0-vs-N1 |
1.605780E-02 |
| N0-vs-N2 |
5.802000E-02 |
| N1-vs-N2 |
8.771600E-01 |
|
|
